Prognostic significance of previous myocardial infarction and previous revascularization in patients undergoing SPECT

Robert J H Miller1, Eyal Klein2, Heidi Gransar2

  • 1Departments of Imaging and Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA; Department of Cardiac Sciences, University of Calgary, Calgary, AB, Canada.

Insights

Prior myocardial infarction (MI) and revascularization without MI are equally significant predictors of mortality in patients undergoing SPECT MPI. This history is especially important for risk stratification in patients without ischemia.

Area of Science:

  • Cardiology
  • Nuclear Cardiology
  • Cardiovascular Imaging

Background:

  • Accurate risk stratification is crucial for managing patients with known coronary artery disease (CAD).
  • Prior myocardial infarction (MI) or revascularization without MI are often considered equivalent indicators of known CAD.
  • The prognostic significance of prior MI versus revascularization without MI in patients undergoing SPECT MPI requires clarification.

Purpose of the Study:

  • To compare the prognostic significance of prior MI and previous revascularization without MI in patients undergoing SPECT MPI.
  • To assess the independent association of prior MI and revascularization with all-cause mortality.
  • To determine if these factors have differential impacts on mortality, particularly in subgroups like patients without ischemia.

Main Methods:

  • A cohort of 50,121 consecutive patients undergoing SPECT MPI between 1992 and 2012 was analyzed.
  • Patient history, including prior MI and revascularization, was prospectively collected.
  • Multivariable Cox regression analysis, adjusted for demographics, medical history, medications, and MPI results, was used to assess associations with all-cause mortality.

Main Results:

  • Prior MI (14.8%) and revascularization without MI (7.2%) were independently associated with increased all-cause mortality (adjusted HR 1.12 and 1.15, respectively).
  • Both prior MI and revascularization without MI were significant predictors of mortality, with no statistically significant difference in their associated risk.
  • These CAD indicators were particularly significant for mortality risk in patients without inducible ischemia on SPECT MPI.

Conclusions:

  • In patients undergoing SPECT MPI, both prior MI and prior revascularization without MI are independent predictors of all-cause mortality with similar risk.
  • The history of CAD, whether prior MI or revascularization, is particularly valuable for risk stratification in patients without evidence of ischemia on MPI.
  • These findings underscore the importance of considering specific CAD history when assessing prognosis in patients undergoing myocardial perfusion imaging.
Abstract